Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

M E Farkouh; J D Greenberg; R V Jeger; K Ramanathan; F W A Verheugt; J H Chesebro; H Kirshner; J S Hochman; C L Lay; S Ruland; B Mellein; P T Matchaba; V Fuster; S B Abramson

doi:10.1136/ard.2006.066001

Article info

Extended reports

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Authors

M E Farkouh The Zena and Michael A Wiener Cardiovascular Institute and The Marie-Josée and Henry R Kravis Center for Cardiovascular Health, Mount Sinai Medical Center, New York, NY, USA PubMed articles Google scholar articles
J D Greenberg New York University Hospital for Joint Diseases, New York, NY, USA PubMed articles Google scholar articles
R V Jeger Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA PubMed articles Google scholar articles
K Ramanathan Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA PubMed articles Google scholar articles
F W A Verheugt Cardiology Department, University Medical Centre, Nijmegen, The Netherlands PubMed articles Google scholar articles
J H Chesebro Division of Cardiology, Mayo Clinic, Jacksonville, Florida, USA PubMed articles Google scholar articles
H Kirshner Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA PubMed articles Google scholar articles
J S Hochman Cardiovascular Clinical Research Center, New York University School of Medicine, New York, NY, USA PubMed articles Google scholar articles
C L Lay Department of Neurology, St Luke’s-Roosevelt Hospital Center, New York, NY, USA PubMed articles Google scholar articles
S Ruland Department of Neurology and Rehabilitation, University of Illinois at Chicago, Illinois, USA PubMed articles Google scholar articles
B Mellein Novartis Pharma, Basel, Switzerland PubMed articles Google scholar articles
P T Matchaba Novartis Pharmaceuticals, East Hanover, NJ PubMed articles Google scholar articles
V Fuster The Zena and Michael A Wiener Cardiovascular Institute and The Marie-Josée and Henry R Kravis Center for Cardiovascular Health, Mount Sinai Medical Center, New York, NY, USA PubMed articles Google scholar articles
S B Abramson New York University Hospital for Joint Diseases, New York, NY, USA PubMed articles Google scholar articles

Correspondence to:
Dr M E Farkouh
Mount Sinai Cardiovascular Institute, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1074, New York, New York 10029, USA; michael.farkouh{at}mssm.edu

View Full Text

Citation

Farkouh ME, Greenberg JD, Jeger RV, et al

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

Annals of the Rheumatic Diseases 2007;66:764-770.

Publication history

Accepted January 21, 2007
First published April 5, 2007.

Online issue publication

January 09, 2022

Article Versions

Previous version (9 January 2022).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password